Deregulation of cell survival in cystic and dysplastic renal development

Kidney International

Volumn 49, Issue 1, 1996, Pages 135-146

  Winyard, Paul J D ^a   Nauta, Jeroen ^b   Lirenman, David S ^b   Hardman, Patricia ^b   Sams, Virginia R ^b   Risdon, R Anthony ^b   Woolf, Adrian S ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CYST; KIDNEY DYSPLASIA; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 0030034551     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.18     Document Type: Article

References (65)

1. KERR JFR, WYLLIE AH, CURRIE AR: Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972
2. COLES HSR, BURNE JF, RAFF MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784, 1993
3. WYLLIE AH: Glucocorticoid-induced thymocye apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556, 1980
4. GAVRELLI Y, SHERMAN Y, BEN-SASSOON SA: Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J Cell Biol 119:493-501, 1992
5. SCHWARTZ LM, SMITH SW, JONES ME, OSBORNE BA: Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 90:980-984, 1993
6. BORTNER CD, OLDENBURG NBE, CIDLOWSKI JA: The role of DNA fragmentation in apoptosis. Trend Cell Biol 5:22-27, 1995
7. VAUX DL: Towards an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90:786-789, 1993
8. OBERHAMMER F, WILSON JW, DIVE C, MORRIS ID, HICKMANN JA, WAKELING AE, WALKER PR, SIKORSKA M: Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679-3684, 1993
9. COLLINS MKL, PERKINS GR, RODRIGUEZ-TARDUCHY G, NIETO MA, LOPÉZ-RIVAS A: Growth factors as survival factors: Regulation of apoptosis. Bio Essays 16:133-138, 1994
10. WYLLIE AH, KERR JFR, CURRIE AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980
11. POTTER EL: Normal and Abnormal Development of the Kidney. Chicago, Year Book Medical Publishers Inc., 1972
12. SAXEN L: Organogenesis of the Kidney. Cambridge, Cambridge University Press, 1987
13. HARDMAN P, KOLATSI M, WINYARD PJ, TOWERS PR, WOOLF AS: Branching out with the ureteric bud. Exp Nephrol 2:211-219, 1994
14. KOSEKI C, HERZLINGER D, AL-AWQATI O: Apoptosis in metanephric development. J Cell Biol 119:1322-1333, 1992
15. WOOLF AS, KOLATSI-JOANNOU M, HARDMAN P, ANDERMARCHER E, MOORBY C, FINE LG, JAT PS, NOBLE MD, GHERARDI E: Roles of hcpatocytc growth factor/scatter factor (HGF/SF) and met in early development of the metanephros, J Cell Biol 128:171-184, 1995
16. WILSON PD, HRENIUK D, GABOW PA: Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J Cell Physiol 150:360-369, 1992
17. AVNER ED, SWEENEY WE, NELSON WJ: Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease. Proc Natl Acad Sci USA 89:7447-7451, 1992
18. WOO DDL, MIAO S, PELAYO J, WOOLF AS: Taxol inhibits congenital polycystic kidney disease progression. Nature 368:750-753, 1994
19. GRANTHAM JJ: 1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol 3:1841-1857, 1992
20. RISDON RA: Renal dysplasia. Part 1: A clinico-pathological study of 76 cases. J Clin Pathok 24:57-71, 1971
21. WOOLF AS: Clinical impact and biological basis of renal malformations. Semin Nephrol 15:361-372, 1995
22. KREIDBERG JA, SARIOLA H, LORING JM, MAEDA M, PELLETIER J, HOUSMAN D, JAENISHI R: WT-1 is required for early kidney development. Cell 74:679-691, 1991
23. VERANI R, WALKER P, SILVA FG: Renal cystic disease of infancy: Results of histochemical studies. Pediatr Nephrol 3:37-42, 1989
24. HOLTHOFFER H, VIRTANEN I, PETTERSSON E, TORNROTH T, ALFTHAN O, LINDER E, MIETTINEN A: Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest 45:391-399, 1981
25. BLAND JM, ALTMANN DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 8476: 307-310, 1986
26. SAMBROOK J, FRITSCH EF, MANIATIS T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989
27. AVNER ED, STUDNICKI FE, YOUNG MC, SWEENEY WE JR, PIESCO NP, ELLIS D, FETTERMAN GH: Congenital murine polycystic kidney disease. Pediatr Nephrol 1:587-596, 1987
28. GATTONE VH II, CALVET JP, COWLEY BD JR, EVAN AP, SHAVER TS, HELMSTADTER K, GRANTHAM JJ: Autosomal recessive polycystic kidney disease in a murine model. A gross and microscopic description. Lab Invest 59:231-238, 1988
29. SAVILL J, SMITH J, SARRAF C, REN Y, ABBOTT F, REES A: Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 42:924-936, 1992
30. SCHUMER M, COLOMBEI, MC, SAWCZUK IS, GOBE G, CONNOR J, O'TOOLE KM, OLSSON CA, WISE GJ, BUTTYAN R: Morphological, biochemical and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838, 1992
31. BEERI R, SYMON Z, BREZIS M, BEN-SASSON SA, BAEHR PH, ROSEN S, ZAGER RA: Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 47:1806-1810, 1995
32. IWATA M, TOROK-STORB B, ZAGER RA: An evaluation of renal tubular DNA laddering in response to oxygen deprivation and oxidant injury. J Am Soc Nephrol 5:1307-1313, 1994
33. FUERSTENBERG SM, TOROK-STRAUB B, ZAGER RA: Evidence against apoptosis as a dominant mechanism for post-ischemic/post-hypoxic proximal tubular necrosis. (abstract) J Am Soc Nephrol 4:735, 1993
34. RACUSEN LC, FIVUSH BA, ANDERSSON H, GAHL WA: Culture of renal tubular cells from the urine of patients with nephropathic cystinosis. J Am Soc Nephrol 1:1028-1033, 1991
35. LAURENT G, TOUBEAU G, HEUSON-STIENNON JA, TULKENS P, MALDAGUE P: Kidney tissue repair after nephrotoxic injury: Biochemical and morphological characterisation. CRC Crit Rev Toxicol 19:147-183, 1988
36. WOO DDL: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333:18-25, 1995
37. ZERRES K, MUCHER G, BACHNER L, DESCHENNES G, EGGERMAN T, KAARIAINEN H, KNAPP M, LENNERT T, MISSELWITZ J, VON MUNLENDAHL KH, NEUMANN HPH, PIRSON Y, RUDNIK-SCHONEBORN S, STEINBICKER V, WIRTH B, SCHARER K: Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-ccn. Nature Genet 7:429-432, 1994
38. EUROPEAN POLYCYSTIC KIDNEY DISEASE CONSORTIUM: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:881-894, 1994
39. EUROPEAN CHROMOSOME 16 TUBEROUS SCLEROSIS CONSORTIUM: Identification and characterisation of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-1315, 1993
40. LATIF F, TORY K, GNARRA J, YAO M, DUH F-M, ORCUTT ML, STACKHOUSE T, KUZMIN I, MODI W, GEIL L, SCHMIDT L, ZHOU F, LI H, WEI MH, CHEN F, GLENN G, CHOYKE P, WALTHER MM, WENG Y, DUAN D-SR, DEAN M, GLAVAC D, RICHARDS FM, CROSSEY PA, FERGUSON-SMITH MA, LE PASLIER D, CHUMAKOV I, COHEN D, CHINAULT AC, MAHER ER, LINEHAN WM, ZBAR B, LERMAN MI: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320, 1993
41. VEIS DJ, SORENSON CM, SHUTTER JR, KORSMEYER SJ: bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 75:229-240, 1994
42. SORENSON CM, ROGERS SA, KORSEMEYER SJ, HAMMERMAN MR: Fulminant mctanephric apoptosis in abnormal kidney development in bcl-2 deficient mice. Am J Physiol 268:73-81, 1995
43. TRUDEL M, D'AGATI V, COSTANTINI F: C-myc as an inducer of polycystic disease in transgenic mice. Kidney Int 39:665-671, 1991
44. COWLEY BD JR, SMARDO FL JR, GRANTHAM JJ, CALVET JP: Elevated c-myc proto-oncogene expression in autosomal recessive polycystic kidney disease. Proc Soc Natl Acad Sci USA 84:8394-8398, 1987
45. HARDING MA, GATTONE VH II, GRANTHAM JJ, CALVET JP: Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse. Kidney Int 41:317-325, 1992
46. HARRINGTON EA, BENNETT MR, FANIDI A, EVAN GI; c-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295, 1994
47. GATTONE VH II, ANDREWS GK, FU-WEN N, CHADWICK LJ, KLEIN RM, CALVET JP: Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Dev Biol 138:225-230, 1990
48. HORIKOSHI S, KUBOTA S, MARTIN GR, YAMADA Y, KLOTMAN PE: Epidermal growth factor (EGF) in the congenital polycystic mouse kidney. Kidney Int 39:57-62, 1991
49. HORIE S, HIGASHIHARA E, NUTAHARA K, MIKAMI Y, OKUBO A, KANO M, KAWABE K: Mediation of renal cyst formation by hepatocyte growth factor. Lancet 344:789-791, 1994
50. YE M, GRANTHAM JJ: The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. N Engl J Med 329:310-313, 1993
51. DUNGAN JS, FERNANDEZ MT, ABBITT PL, THIAGARAJAH S, HOWARDS SS, HOGGE WA; Multicystic dysplastic kidney: Natural history of prenatally detected cases. Prenat Diag 10:175-182, 1990
52. MESROBIAN H-GJ, RUSHTON HG, BULAS D: Unilateral renal agenesis may result from in utero regression of multicystic dysplasia. J Urol 150:793-794, 1993
53. AL-KHALDI N, WATSON AR, ZUCOLLO J, TWINING P, ROSE DH: Outcome of antenatally detected cystic dysplastic kidney disease. Arch Dis Child 70:520-522, 1994
54. WINYARD PJD, RISDON RA, WOOLF AS: WT1 expression in the absence of BCL2 may explain excessive apoptosis which occurs in human kidney malformations. (abstract) J Am Soc Nephrol 6:729, 1995
55. LEBRUN DP, WARNKE RA, CLEARY ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743-753, 1993
56. BERMAN D, MAIZELS M: The role of urinary obstruction in the genesis of renal dysplasia. J Urol 128:1091-1100, 1982
57. STEINHARDT GF, VOGLER G, SALINAS-MADRIGAL L, LEREGINA M: Induced renal dysplasia in the young pouch opossum. J Ped Surg 23:1127-1130, 1988
58. GONZALEZ R, REINBERG Y, BURKE B, WELLS T, VERNIER RL: Early bladder outlet obstruction in fetal lambs induces renal dysplasia and the prune-belly syndrome. J Pediatr Surg 25:342-334, 1990
59. CONNOR J, BUTTYAN R, OLSSON CA, D'AGATI V, O'TOOLE K, SAWCZUK IS: SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int 39: 1098-1103, 1991
60. KENNEDY WA II, STERNBERG A, LACKGREN G, HERNSLE TW, SAWCZUK IS: Renal tubular apoptosis after partial ureteral obstruction. J Urol 152:658-664, 1994
61. PIMENTEL JL, KOPP JB, SUNDEN JL, MARTINEZ-MALDONADO M: TGF-β induction in unilateral ureteric obstruction. (abstract) J Am Soc Nephrol 4:474, 1993
62. SCHUCHARDT A, D'AGATI V, LARSSON-BLOMBERG L, COSTANTINI F, PACHNIS V: Defects in kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380-383, 1994
63. STARK K, VAINIO S, VASSILEVA G, MCMAHON AP: Epithelial transformation of metanephric mesenchymc in the developing kidney regulated by Wnt-4. Nature 372:679-683, 1994
64. MENDELSOHN C, LOHNES D, DECIMO D, LUFKIN T, LEMEUR M, CHAMBON P, MARK M: Function of the retinoic acid receptors (RAR) during development. Development 120:2749-2771, 1994
65. KENNEDY WA II, BUTTYAN R, SAWCZUK IS: Epidermal growth factor (EGF) suppresses renal tubular apoptosis following ureteral obstruction. (abstract) J Am Soc Nephrol 4:738, 1993